|
CAS
|
112809-51-5
|
|
中文名称
|
来曲唑
|
|
英文名称
|
Letrozole
|
|
别名
|
1-[双(4-氰基苯基)甲基]-1,2,4-三氮唑
|
|
纯度
|
HPLC≥98%
|
|
分子式
|
C17H11N5
|
|
分子量
|
285.31
|
|
外观（性状）
|
White to off-white Solid
|
|
储存条件
|
Powder : 2-8℃, 2 years; In solvent(母液): -20℃, 1 month; -80℃, 6 months
|
|
溶解性
|
Soluble in DMSO ≥ 25mg/mL
|
|
MDL
|
MFCD00866241
|
|
EC
|
EINECS 675-034-8
|
|
InChIKey
|
HPJKCIUCZWXJDR-UHFFFAOYSA-N
|
|
InChI
|
InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H
|
|
PubChem CID
|
3902
|
|
SMILES
|
N#CC1=CC=C(C(N2C=NC=N2)C3=CC=C(C#N)C=C3)C=C1
|
|
描述
|
(It is a new generation of highly selective aromatase inhibitors. By inhibiting aromatase, the level of estrogen is reduced, thereby eliminating the stimulating effect of estrogen on tumor growth.)
|
|
靶点
|
Aromatase
|
|
通路
|
Endocrinology & Hormones
|
|
规格
|
50mg 10mM*1mL (in DMSO) 100mg
|
|
单位
|
瓶
|
